The global Chiba needle market is estimated to be valued at USD 1.30 Bn in 2026 and is expected to reach USD 2.00 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.35% from 2026 to 2033. The global Chiba needle market is a niche segment within medical devices industry. Chiba needles are thin-walled needles with beveling, used in percutaneous procedures, biopsies, and interventional radiology. These needles are used for precise tissue sampling with minimum tissue trauma, accessing hard-to-reach organs and lesions.
Chiba needles are used in various gauges and are used for varied purposes. They are used in hospitals, diagnostic centers, and healthcare settings. The Chiba needle market is growing due to an increase in cancer, liver disease, and other conditions in which precise tissue diagnosis is required. In addition, an increase in minimally invasive procedures is also contributing to market growth. Technological advancements in Chiba needles are also contributing to market growth.
Market Dynamics
The market for Chiba needles is influenced by the growing incidence rate of cancer and other life-threatening diseases that require accurate tissue sampling and biopsy procedures. The growing trend for minimally invasive procedures, which is being fulfilled by Chiba needles due to their accurate diagnostic procedures, minimal pain, quick recovery, and fewer complications drive the market growth. The improvement in stylets, visibility, and ergonomic design of needles, along with improvements in healthcare facilities in developing countries and healthcare spending in developing countries, further propels the market worldwide.
Despite these driving factors, there are challenges in the market that include the expensive nature of sophisticated needles, which might restrict growth in cost-conscious markets. The regulatory hurdles for medical devices are also stringent, which might result in higher costs for developing these devices. The procedural risks, though negligible, might also create some apprehensions for healthcare professionals. Another factor is that other biopsy and sampling modalities also exist in the market, making it competitive.
However, there exists many opportunities in this market, which include image-guided procedures that include CT and ultrasound guidance for increased accuracy and better results. The growing population in the age group that is susceptible to diseases that require tissue diagnosis is also an opportunity. The increased accessibility of healthcare in developing nations and innovations in smart needles that have real-time feedback also provide scope for growth.
Key Features of the Study
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on 'Chiba Needle Market' - Global forecast to 2033
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients